App-Quantinova.ai

Infectious morbidity following cesarean deliveries: A comparison of barbed to standard suture for myometrial closure

Raanan Meyer - Society for Maternal-Fetal Medicine (SMFM) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

N/A

Outcomes associated with trial of labor after cesarean in women with one versus two prior cesarean deliveries after a change in clinical practice guidelines in an academic hospital

Christina Davidson - Society for Maternal-Fetal Medicine (SMFM) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

N/A

Developing a comprehensive quality and patient safety program to effectively reduce obstetrical adverse events in an integrated children’s hospital system

Gary Dildy - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Risk factors for developing septic pelvic thrombophlebitis in a high-risk cohort

Sarah K. Dotters-Katz - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

N/A

The cost-effectiveness of prophylactic, post-cesarean antibiotics in obese women for the prevention of surgical site infections

Amy M. Valent - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Metronidazole

The “night & weekend effect” in obstetrics: truth, or artifact?

Brett D. Einerson - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Optimal strategy for venous thromboembolism prophylaxis following cesarean delivery: a decision analysis

Emily Bunce - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Heparin

Implementation of a risk-based low-molecular weight heparin protocol for venous thromboembolism prevention in postpartum women

Elizabeth H. Robison - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Heparin

Maternal and neonatal outcomes associated with non-medically indicated induction of labor at term compared with expectant management in morbidly obese women

Tetsuya Kawakita - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Safety of routine use of pharmacological thromboprophylxi in post cesarean section patients

Hiba Mustafa - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Heparin

Non-medically indicated induction of labor compared with expectant management in nulliparous women 35 years of age or older

Tetsuya Kawakita - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Timing of delivery in women with antiphospholipid antibody syndrome

Marissa L. Luck - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

N/A

Operative vaginal delivery is a safe option in women undergoing a trial of labor after prior cesarean delivery (TOLAC)

Erin Krizman - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

Methadone hydrochloride

The role of obesity in postpartum complications among women infected with HIV

Corley Rachelle Price - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Readmission for postpartum stroke

Gloria Too - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Venous thromboembolism prophylaxis during antepartum hospitalizations

Anne H. Mardy - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Hypoalbuminemia is associated with increased 30-day complications following rectourethral fistula repair: A NSQIP study

M. Ryan Farrell - New England Section of the American Urological Association (NEAUA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

SECONDARY POLYCYTHEMIA IN MEN RECEIVING TESTOSTERONE THERAPY INCREASES RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND VENOUS THROMBOEMBOLISM: INSIGHTS FROM A GLOBAL HEALTH RESEARCH NETWORK

Jesse Ory - American Society for Reproductive Medicine (ASRM) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Purinergic Receptor Function In The Middle Cerebral Artery From Clopidogrel-treated Rabbits

Dawn Kuszynski - American Society of Hypertension (ASHy) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Utilization, Effectiveness, and Safety of Tranexamic Acid Use in Hip Fracture Surgery

Zoe B. Cheung - Orthopaedic Trauma Association (OTA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Tranexamic acid

Filters

7277 Abstracts